Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Circulating Inflammatory Markers After Stroke
NCT06062277Phase 2Unknown
- Sponsor
- University College Dublin
- Start
- Oct 2023
- Primary completion
- Oct 2024
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in ischemic stroke, atherosclerosis, sponsored by University College Dublin. Status: unknown.
02
Drugs
colchicine
03
Conditions
ischemic strokeatherosclerosis
Beyond the preview
Go deeper on NCT06062277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06062277.